Fun-IVCM reveals inflammation clues in DED
A new imaging approach, Fun-IVCM, is able to track the presence of inflammation in dry eye disease
Drs Ching Yi Wu and Mengliang Wu6 min read
Advertisement
A new imaging approach, Fun-IVCM, is able to track the presence of inflammation in dry eye disease
Dry eye disease (DED) is multifactorial in origin and, while intrinsic ocular surface pathology often garners the most attention, mechanical contributors, particularly those related to eyelid position and function, are sometimes underrecognised. In clinical oculoplastics practice, eyelid malposition
Since dry eye often needs long-term and regular treatment with eye drops, compliance is important to achieve favourable therapeutic outcomes. Difficulty in squeezing eye drop containers has been reported as one of the major barriers for eye drop compliance1,2.
Dry, gritty, burning eyes? The most common culprit is meibomian gland dysfunction (MGD). These tiny glands, nestled within our eyelids, should secrete a lubricous oily substance termed meibum, which p
Ensuring evidence-based best practice reaches patients, both locally and globally, is at the heart of what we do as clinical educators. At the 2024 Tear Film & Ocular Surface Society (TFOS) conference in Venice, a chance meeting between then BCLA president Sarah Farrant, Indian ophthalmologist A
An in-practice perspective on the clinical utility of topical ciclosporin for dry eye disease
Recurrent chalazia present a challenge in clinical practice. Photobiomodulation is a novel approach to management, which, as described in this patient case, can offer encouraging results. A 42-year-
Specsavers is extending its eyecare services, introducing intense pulsed light (IPL) and low-level light therapy (LLLT) treatments for dry eye disease (DED) to four New Zealand stores: Te Rapa, Hornby
Young people are not immune to the effects of dry eye disease (DED)1. The average university student spends upwards of eight hours each day staring at screens while often running low on sleep. Therefore, it is no surprise that we are seeing a high number of students with DED2,3. But are these lifest
Traditional dry eye disease (DED) management strategies encompass artificial tears, anti-inflammatory agents and punctal plugs. However, a subset of patients remains refractory to these treatments, necessitating alternative therapeutic approaches. While dry eye can be an inadvertent side-effect of b
A Swedish study has shown that dermatochalasis surgery (blepharoplasty) of the upper eyelid improved headache-related quality of life and may not be as worrisome for dry eye as previously thought. A
For me, it all began with a moongate. While a graduate student at Dartmouth Medical School (Hanover, US) in the mid-1970s, one of my mentors, the internationally renowned corticosteroid endocrinologist, the late Emeritus Professor Allan Munck, organised an exclusive meeting of approximately 25 stero